Clinical Trial Update: Single Patient Protocol for Donor HCV-positive to Recipient HCV-negative Kidney Transplant in a Patient at Risk for Loss of Dialysis Access [Phase 4]

View source ↗

Summary

Clinical trial for a single-patient protocol involving donor HCV-positive to recipient HCV-negative kidney transplant was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Hepatitis C

Snippet

Sponsor: Massachusetts General Hospital | Conditions: End Stage Renal Disease, Chronic Hepatitis c | Phase 4 | Status: WITHDRAWN